Logo-bi
Bioimpacts. 2020;10(3): 205-206. doi: 10.34172/bi.2020.25
PMID: 32793443        PMCID: PMC7416005

Letter to the Editor

Computational-based drug repurposing methods in COVID-19

Yosef Masoudi-Sobhanzadeh 1 * ORCID

Cited by CrossRef: 7


1- Mohanty S, Rashid M, Mohanty C, Swayamsiddha S. Modern computational intelligence based drug repurposing for diabetes epidemic. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(4):102180 [Crossref]
2- Tian X, Shen L, Gao P, Huang L, Liu G, Zhou L, Peng L. Discovery of Potential Therapeutic Drugs for COVID-19 Through Logistic Matrix Factorization With Kernel Diffusion. Front Microbiol. 2022;13 [Crossref]
3- Kumar A, Kumar D, Kumar R, Singh P, Chandra R, Kumari K. DFT and docking studies of designed conjugates of noscapines & repurposing drugs: promising inhibitors of main protease of SARS-CoV-2 and falcipan-2. Journal of Biomolecular Structure and Dynamics. 2022;40(6):2600 [Crossref]
4- Ibrahim I, Elfiky A, Elgohary A. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective. Biochemical and Biophysical Research Communications. 2021;562:89 [Crossref]
5- Masoudi-Sobhanzadeh Y, Salemi A, Pourseif M, Jafari B, Omidi Y, Masoudi-Nejad A. Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries. 2021;22(6) [Crossref]
6- Arabi Bulaghi Z, Habibizad Navin A, Hosseinzadeh M, Rezaee A. World competitive contest-based artificial neural network: A new class-specific method for classification of clinical and biological datasets. Genomics. 2021;113(1):541 [Crossref]
7- Hooshmand S, Zarei Ghobadi M, Hooshmand S, Azimzadeh Jamalkandi S, Alavi S, Masoudi-Nejad A. A multimodal deep learning-based drug repurposing approach for treatment of COVID-19. Mol Divers. 2021;25(3):1717 [Crossref]
8- Speth R. An opinion on the impacts of COVID-19 worldwide. Bioimpacts. 2022;12(3):293 [Crossref]

BioImpacts, as a peer-reviewed international journal, publishes all types of papers on bench-to-bedside translational aspects of pharmaceutical and biomedical sciences. As a "Publish Free" and "Access Free" journal, BioImpacts follows a constructive peer-review process with free editing service to benefit the scientific community worldwide.